Healthcare -
Biotechnology - NASDAQ - US
$ 5.435
-1.54 %
$ 372 M
Market Cap
-0.95
P/E
PHAT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities PHAT - Phathom Pharmaceuticals, Inc.
368 M
LAST VALUE
186.74%
2 YEAR CAGR
186.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR